- Home
- Managing CMR
Managing Cardiometabolic Risk
Targeting Traditional CVD Risk Factors in Patients with Abdominal Obesity
Numerous organizations have published an array of guidelines on managing acknowledged risk ...
READ MOREResidual Cardiometabolic Risk of Treated Patients
Numerous clinical trials have shown the benefits of treating traditional risk factors to ward off ...
READ MOREEffects of Weight Loss on Adipose Tissue Distribution
It is well documented that weight loss has a positive effect on all obesity-related metabolic
READ MOREManaging Cardiometabolic Risk in Abdominally Obese Patients
Despite evidence that intra-abdominal (visceral) obesity is the most dangerous form of obesity ...
READ MORE
Which factors/markers do you think will emerge as key predictors of global CMR beyond the Framingham risk score?
More
Tesaglitazar, a dual peroxisome proliferator-activated receptor alpha/gamma agonist, improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Atherosclerosis 2008;197:355-62
More
Evidence for a greater relative accumulation of intra-abdominal adipose tissue (AT) in Japanese than Caucasian Americans
More